We have sufficient APIs to manufacture drugs for next three months: Sadananda Gowda
In the backdrop of the prevailing coronavirus scare across the country after multiple new positive cases surfaced in India, the Union Minister for Chemicals and Pharmaceuticals assured that there was no shortage of any Active Pharma Ingredients (APIs) or medicines in the country.
Union Minister DV Sadananda Gowda, while addressing a FICCI conclave - ‘India Pharma and India Medical Device 2020’ here, tried to pacify the panic created around the coronavirus spread in the country. “There are certain confusion regarding to supply and availability of medicines. Certainly, we have got sufficient medicines and sufficient APIs so that for another three months to ensure there is no shortage in producing medicines,” he said.
Addressing the event, jointly organised by FICCI and the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, the Minister stated that the Prime Minister has formed a group of ministers, which is monitoring the situation closely.
“Each and every person coming into the country is being screened at the airports itself. We have also created quarantine facilities in the country,” the Minister said, adding that a group of secretaries, headed by Health Secretary, meet everyday and remain in touch with Prime Minister’s Office on regular basis.
He also stated that the Indian pharma industry is likely to reach $100 billion in its overall size, while medical devices sector is slated to touch $50 billion by 2025. “India today is a major hub for medical devices and diagnostics. There has to be certain interventions by the government as far as polices are concerned,” he added.
In his address, Gujarat Chief Minister Vijay highlighted the State’s contribution to the national GDP said that Gujarat is one of the few States in the country to provide all necessary support to strengthen the pharma and medical device companies.
Mansukh Mandaviya, Minister of State (I/C) for Shipping and Chemicals & Fertilisers, said that at a time when the world is in recession, the Indian pharma sector is growing at 10 per cent and medical devices sector is growing at 20-25 per cent. He further added that government is working on bringing new policy to strengthen the Indian API market.
Thank you for being a loyal user of Portfolio.
Portfolio will be a paid section hereon.
Please Subscribe to get access to one of our early bird packs.
Or click on Free Trial to get 14 days free trial.
What You'll Get
-
Web + Mobile
Access exclusive content of the Hindu Businessline across desktops, tablet and mobile device.
-
Exclusive Portfolio and Investment Advice, Banking, Lifestyle and Specials
Get diverse set of perspectives from our trusted experts on Portfolio, Banking, Economy, Environment and others.
-
Ad free experience
Experience cleaner site with zero ads and faster load times.
-
Personalised dashboard
Customize your preference and get a personalized recommendation of stories based on your interest.
Published on
March 05, 2020
A letter from the Editor
Dear Readers,
The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.
Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.
In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.
We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.
But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.
I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.
A little help from you can make a huge difference to the cause of quality journalism!
Support Quality Journalism
Please Email the Editor